195 related articles for article (PubMed ID: 27663616)
21. Interleukin-17 is involved in orthodontically induced inflammatory root resorption in dental pulp cells.
Nakano Y; Yamaguchi M; Shimizu M; Kikuta J; Yoshino T; Tanimoto Y; Kasai K
Am J Orthod Dentofacial Orthop; 2015 Aug; 148(2):302-9. PubMed ID: 26232839
[TBL] [Abstract][Full Text] [Related]
22. Receptor activator of nuclear factor-kappa ligand, OPG, and IGF-I expression during orthodontically induced inflammatory root resorption in the recombinant human growth hormone-treated rats.
Hu Y; Liu W; Liu Z; Kuang W; He H
Angle Orthod; 2015 Jul; 85(4):562-9. PubMed ID: 25184787
[TBL] [Abstract][Full Text] [Related]
23. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
24. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
25. Osteoprotegerin deficiency causes morphological and quantitative damage in epithelial rests of Malassez.
Wang Y; Liu M; Deng S; Sui X; Fan L; Zhang Q
J Mol Histol; 2018 Jun; 49(3):329-338. PubMed ID: 29644561
[TBL] [Abstract][Full Text] [Related]
26. Cementocytes Express Receptor Activator of the Nuclear Factor Kappa-B Ligand in Response to Endodontic Infection in Mice.
De Rossi A; Fukada SY; De Rossi M; da Silva RA; Queiroz AM; Nelson-Filho P; da Silva LA
J Endod; 2016 Aug; 42(8):1251-7. PubMed ID: 27342005
[TBL] [Abstract][Full Text] [Related]
27. CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption.
Heinrich J; Bsoul S; Barnes J; Woodruff K; Abboud S
Arch Oral Biol; 2005 Oct; 50(10):897-908. PubMed ID: 16137499
[TBL] [Abstract][Full Text] [Related]
28. Expression of Toll-like receptors 2 and 4 and the OPG-RANKL-RANK system in inflammatory external root resorption and external cervical resorption.
Lin YP; Love RM; Friedlander LT; Shang HF; Pai MH
Int Endod J; 2013 Oct; 46(10):971-81. PubMed ID: 23521017
[TBL] [Abstract][Full Text] [Related]
29. [The effect of ferric ion on the differentiation of osteoclast and bone resorption].
Jia P; He YF; Gao C; Du HB; Hu ZY; Feng XQ; Li BY; Zhang ZL; Xu YJ; Lin H
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2214-8. PubMed ID: 23158430
[TBL] [Abstract][Full Text] [Related]
30. RANKL increase in compressed periodontal ligament cells from root resorption.
Yamaguchi M; Aihara N; Kojima T; Kasai K
J Dent Res; 2006 Aug; 85(8):751-6. PubMed ID: 16861294
[TBL] [Abstract][Full Text] [Related]
31. TGF-β and Physiological Root Resorption of Deciduous Teeth.
Shimazaki E; Karakida T; Yamamoto R; Kobayashi S; Fukae M; Yamakoshi Y; Asada Y
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035998
[TBL] [Abstract][Full Text] [Related]
32. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
33. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
34. A qualitative investigation of RANKL, RANK and OPG in a rat model of transient ankylosis.
Curl L; Tan CW; Dreyer CW; Sampson W
Aust Orthod J; 2014 Nov; 30(2):143-51. PubMed ID: 25549516
[TBL] [Abstract][Full Text] [Related]
35. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
[TBL] [Abstract][Full Text] [Related]
36. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
Yamazaki H; Sasaki T
J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
[TBL] [Abstract][Full Text] [Related]
37. OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell.
Chen J; He JQ; Zhen SY; Huang LQ
Rheumatol Int; 2012 Dec; 32(12):3993-8. PubMed ID: 22210270
[TBL] [Abstract][Full Text] [Related]
38. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
Sheng ZF; Xu K; Ma YL; Liu JH; Dai RC; Zhang YH; Jiang YB; Liao EY
Osteoporos Int; 2009 Jan; 20(1):151-9. PubMed ID: 18496637
[TBL] [Abstract][Full Text] [Related]
39. Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice.
Sakakura Y; Tsuruga E; Irie K; Hosokawa Y; Nakamura H; Yajima T
J Anat; 2005 Oct; 207(4):325-37. PubMed ID: 16191162
[TBL] [Abstract][Full Text] [Related]
40. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
Evans CE; Mylchreest S; Andrew JG
BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
